Cloning News and Research

RSS

Roundup: Minn. officials reach deal to end shutdown; Calif. wrestling with adult day care benefits

Gov. Mark Dayton had to disappoint some of his strongest political supporters to come up with the deal Thursday that will end Minnesota's government shutdown. ... But Dayton did extract things from Republicans that they hadn't been willing to yield at shutdown time. The Republican "policy issues" that run throughout the Republican budget bills will disappear.

16 Jul 2011

Study about U.S. attitudes toward human embryonic stem cell research

While research using human embryonic stem cells has roused political controversy for almost two decades, little has been done to scientifically assess American attitudes on the subject. New research from the University of Nevada, Reno provides decision-makers with a much clearer picture of how their constituents truly feel about the subject.

30 Jun 2011

Researchers discover new mechanism for origin of Barrett's esophagus

Researchers have discovered a new mechanism for the origin of Barrett's esophagus, an intestine-like growth in the esophagus that is triggered by chronic acid reflux and often progresses to esophageal cancer.

24 Jun 2011

Geron comments on recent European telomerase peptide cancer vaccine patents

Geron Corporation today commented on a ruling from the European Patent Office with regard to its European patent 084139, and the issuance of a second Geron patent covering telomerase peptides, EP1783139.

10 May 2011

IQ Therapeutics completes dosing in IQNLF Phase I trial for anthrax

IQ Therapeutics has completed the dosing of antibody IQNLF in a Phase I clinical trial. A total of 36 healthy volunteers participated in the randomized, placebo controlled, double blind, single dose-escalating study, intended to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of IQNLF.

27 Apr 2011

Scientists discover special mechanism that delays ageing

Animals that reproduce asexually by somatic cloning have special mechanisms that delay ageing provide exceptionally good health. Scientists at the University of Gothenburg have shown how colony-forming ascidians can activate the enzyme telomerase, which protects DNA. This enzyme is more active also in humans who attain an advanced age.

22 Apr 2011

Viewpoints abound on impact of Ryan plan, government showdown

If the federal government shuts down at midnight on Friday — which seems likely unless negotiations take a sudden turn toward rationality — it will not be because of disagreements over spending. It will be because Republicans are refusing to budge on these ideological demands: No federal financing for Planned Parenthood. ... No local financing for abortion services in the District of Columbia. ... No funds for health care reform.

8 Apr 2011

Springer editor receives ERC Advanced Grants for biosilicate research

The European Research Council has awarded one of this year's ERC Advanced Grants to Springer editor Dr. Werner M-ller, thus supporting his well-established research in the field of biosilicates with prize money of 2.2 million euros.

19 Mar 2011

Scientific advances at Scripps Research lay foundation for new lupus drug Benlysta

Scientific advances at The Scripps Research Institute were key to laying the foundation for the new drug Benlysta® (belimumab), approved today by the U.S. Food and Drug Administration. Benlysta®, which treats the most common type of lupus, is the first in a new class of pharmaceuticals that prevents the body from attacking its own critical tissues.

11 Mar 2011

Panasonic to offer new high definition patient room display for hospitals

Panasonic Solutions Company, provider of collaboration, information-sharing and decision-support solutions for healthcare, government and commercial enterprises, today announced it will offer a new high definition, 32", hospital-grade, patient room display later this year.

From PHC Europe B.V. 21 Feb 2011

CLC bio releases several desktop software packages for analyzing biological sequence data

Today, CLC bio announced the release of several desktop software packages for analyzing biological sequence data including the popular products such as the CLC Main Workbench 6.0 and CLC DNA Workbench 6.0.

17 Feb 2011

Stem cell exhibition to broaden debate on the issue

The topic remains complex and controversial, the technology innovative and promising, and the debate, on stem-cell research, continues unabated. And now, the subject is receiving the attention of a group not normally associated with scientific discoveries. University of Alberta printmaking professor, Sean Caulfield, along with U of A Health Law Institute research director and researcher, Tim Caulfield, have brought together a group of visual artists from Europe and North America to contribute to the stem-cell debate that often pits politicians, scientists, pundits and religious leaders against each other.

17 Jan 2011

Novel AAV gene therapy offers various advantages

A new, simplified method for producing large amounts of viral vector cassettes capable of shuttling genes into host cells will help advance the promising field of gene therapy as applications move into large animal studies and human clinical trials.

6 Jan 2011

Research finds alteration in KBTBD13 protein causes nemaline myopathy

Researchers from the Department of Anesthesiology, Uniformed Services University of the Health Sciences (USU), along with research teams from the National Institutes of Health and from Australia, the Netherlands and Spain, have identified a novel gene on chromosome 15q that, when altered, causes nemaline myopathy with cores, a rare inherited muscle disorder. The gene encodes a member of the BTB/Kelch family of proteins.

30 Nov 2010

Embryonic stem cell research has not made good on taxpayer investment

In 2004 Robert Klein, chairman of the California Institute of Regenerative Medicine (CIRM), helped pass Proposition 71, establishing the CIRM with a state taxpayer-funded $3 billion budget for ten years. The measure was passed with promises of affordable cures for virtually all diseases, cures specifically from embryonic stem cells and cloning, as well as tremendous financial payback for the citizens of California. The Los Angeles Times recently noted that Klein plans to seek up to $3 billion more from state taxpayers for his stem cell fiefdom.

25 Nov 2010

Garvan Institute professor receives 2010 Prime Minister's Prize for Science

Professor John Shine AO FAA, Executive Director of Sydney's Garvan Institute of Medical Research, received the 2010 Prime Minister's Prize for Science, the nation's most highly respected award for scientific achievement, in Parliament House tonight.

17 Nov 2010

Australian stem cell line offers fresh approach to diabetes cure

Australian researchers have developed the country’s first diabetes specific stem cell line, a major advance for patients suffering from the chronic disease.

21 Oct 2010

Father of IVF acknowledged with a Nobel prize

Professor Robert Edwards who came to be known as the “father of In Vitro fertilization” (IVF) has won this year's Nobel prize in medicine. He is 85 and has won the 2010 Nobel Prize in Physiology and Medicine for his pioneering work on the in vitro fertilisation of human eggs that led to the birth of the world's first IVF baby, Louise Brown, in 1978. When he had started off initially his funding request for IVF research was turned down by Britain’s Medical Research Council (MRC) in the 1970s. His co-worker the gynaecologist Patrick Steptoe, died in 1988. Professor Edwards becomes the sole recipient of this award since it cannot be awarded posthumously.

4 Oct 2010

Study demonstrates potential of nontoxic envelope proteins as an alternative to pseudotype lentiviral vectors

Therapeutic lentiviral vectors are emerging as vital tools for molecular medicine as evidenced by the growing number of clinical trials using these vector systems. From a basic research standpoint, lentiviral vectors are very intriguing substrates. On the one hand, the HIV-1 genome offers expanded cloning capacity and the capability to transduce nondividing cells such as hematopoietic stem cells (HSCs) and neurons.

4 Oct 2010

76% of Americans oppose cloning human embryos for research

As the U.S. Senate prepares to hold a hearing on human embryonic stem cell research (hESCR), a new public opinion poll shows that a plurality of Americans (47 percent) oppose federal funding of stem cell research that involves destroying human embryos, while only thirty-eight percent (38 percent) support such funding. The poll, conducted by ICR / International Communications Research, surveyed 1,006 adults September 8-14. It was commissioned by the Secretariat of Pro-Life Activities at the U.S. Conference of Catholic Bishops (USCCB).

17 Sep 2010